Leukemia Cell Surface Antigen Modulation Induced By Dual CD19/CD20 Chimeric Antigen Receptor (CAR)-T Cells

被引：0
|
作者：
Schneider, Dina [1 ]
Xiong, Ying [1 ]
Wu, Darong [1 ]
Nolle, Volker [2 ]
Schmitz, Sarah [2 ]
Kaiser, Andrew [2 ]
Dropulic, Boro [3 ]
Orentas, Rimas [3 ]
机构：
[1] Miltenyi Biotec Co, Lentigen Technol Inc, Translat Res & Dev, Gaithersburg, MD USA
[2] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
[3] Miltenyi Biotec Co, Lentigen Technol Inc, Gaithersburg, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
273
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [21] CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia
    Yang, Na
    Zhang, Caili
    Zhang, Yingchun
    Fan, Yuting
    Zhang, Jing
    Lin, Xiaojin
    Guo, Ting
    Gu, Yangzuo
    Wu, Jieheng
    Gao, Jianmei
    Zhao, Xing
    He, Zhixu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [22] Genetic Mechanism of Leukemia Relapse Following CD19 Chimeric Antigen Receptor T Cell Therapy
    Qiu, Songlin
    Pan, Ye
    Shi, Shenyan
    Omotoyosi, Fapohunda Funmilayo
    Chen, Keping
    Guo, Zhigang
    Lu, Peng
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (05) : 335 - 341
  • [23] Novel Antigen-Specific Expansion of T Cells Transduced with a CD19 Chimeric Antigen Receptor
    Lee, Daniel W.
    Kochenderfer, James N.
    Rader, Christoph
    Orentas, Rimas J.
    Mackall, Crystal L.
    BLOOD, 2010, 116 (21) : 1337 - 1337
  • [24] Bicistronic CAR Constructs for Dual CD19 and CD20 Targeting
    Yang, Shicheng
    Lam, Norris
    Kochenderfer, James N.
    MOLECULAR THERAPY, 2020, 28 (04) : 149 - 150
  • [25] Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells
    Sakai, Osamu
    Ogino, Shoji
    Tsukui, Toshihiro
    Igase, Masaya
    Mizuno, Takuya
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2021, 83 (10): : 1495 - 1499
  • [26] Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Hay, Kevin A.
    Turtle, Cameron J.
    DRUGS, 2017, 77 (03) : 237 - 245
  • [27] Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Kevin A. Hay
    Cameron J. Turtle
    Drugs, 2017, 77 : 237 - 245
  • [28] Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function
    Veliz, Kimberly
    Shen, Feng
    Shestova, Olga
    Shestov, Maksim
    Shestov, Alexander
    Sleiman, Sara
    Hansen, Tyler
    O'Connor, Roddy S.
    Gill, Saar
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (02):
  • [29] Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy
    Perna, Fabiana
    Sadelain, Michel
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S221 - S225
  • [30] Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
    Joseph A. Fraietta
    Simon F. Lacey
    Elena J. Orlando
    Iulian Pruteanu-Malinici
    Mercy Gohil
    Stefan Lundh
    Alina C. Boesteanu
    Yan Wang
    Roddy S. O’Connor
    Wei-Ting Hwang
    Edward Pequignot
    David E. Ambrose
    Changfeng Zhang
    Nicholas Wilcox
    Felipe Bedoya
    Corin Dorfmeier
    Fang Chen
    Lifeng Tian
    Harit Parakandi
    Minnal Gupta
    Regina M. Young
    F. Brad Johnson
    Irina Kulikovskaya
    Li Liu
    Jun Xu
    Sadik H. Kassim
    Megan M. Davis
    Bruce L. Levine
    Noelle V. Frey
    Donald L. Siegel
    Alexander C. Huang
    E. John Wherry
    Hans Bitter
    Jennifer L. Brogdon
    David L. Porter
    Carl H. June
    J. Joseph Melenhorst
    Nature Medicine, 2021, 27 : 561 - 561
12345